To examine the role of the Bcl2/Bax ratio change in the synthetic lethal phenotype of PTEN-/- CRC cells, we first used a Bcl2 inhibitor and siRNA on the cell viability in the PTEN-isogenic cell pair. The gene discussed is BCL2; the disease is colorectal carcinoma.